Clinical Trials on new therapies for MS based at the National Hospital for Neurology and Neurosurgery (NHNN) and the Leonard Wolfson Experimental Neurology Centre (LWENC) in Queen Square:
- Octopus: a new trial for progressive MS
- Alexander Disease Trial
- NMR Research Unit Trials Office
New Clinical Trials that are based in other London Hospitals, with MRI carried out in the Queen Square Multiple Sclerosis Centre:
AttackMS: A new Clinical Trial that is based in other London Hospitals, with MRI carried out in the Queen Square Multiple Sclerosis Centre. This trial is on Natalizumab for treatment of inflammatory demyelination suggestive of MS, or definite MS, at first presentation.
- Video: AttackMS: assessing the feasibility of multiple sclerosis treatment within 14 days of presentation.
- Video: Why has the AttackMS trial been suggested to me? Some patients explain more.
ChariotMS: This is a new multi-centre (20 sites across the U.K) trial of cladribine in patients with advanced MS.
Page updated 09-05-2023.